HealthcareServices

Preclinical Imaging Market Size and Demand Forecast 2026–2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the preclinical imaging market from 2026–2035 with trusted insights from The Business Research Company

How much is the Preclinical Imaging Market valued at in 2026, and what valuation is forecast for 2030?

The preclinical imaging market has experienced robust growth in recent years. It is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing application of animal models in biomedical research, the expansion of oncology and neurology research, the rising acceptance of non-invasive imaging techniques, the growth in preclinical drug testing activities, and the availability of advanced imaging reagents.

The preclinical imaging market size is forecast to experience significant expansion over the next few years, with its value expected to reach $5.18 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth throughout the forecast period stems from factors such as the rising demand for real-time disease visualization, increased investments in translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the growing deployment of advanced contrast agents. Prominent trends anticipated during this period include the increased adoption of multi-modal imaging platforms, a rise in the use of high-resolution imaging systems, the growing integration of imaging with data analytics, the expansion of longitudinal disease monitoring studies, and an enhanced focus on translational imaging accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Drivers Are Influencing The Growth Of The Preclinical Imaging Market?

The future expansion of the preclinical imaging market is anticipated to be driven by the rising prevalence of chronic diseases. These conditions are defined as long-lasting health issues typically enduring for at least three months, frequently necessitating continuous medical care, and capable of profoundly affecting an individual’s quality of life. Preclinical imaging instruments are employed to identify chronic diseases by visualizing aspects such as bone structure and lung function. Additionally, these tools aid in studying chronic diseases, allowing for visualization of disease progression and enhancing comprehension. For example, data from February 2024 published by the World Health Organization (WHO), the international public health agency based in Switzerland, indicated that NCDs account for 75% (three-quarters) of global deaths. Consequently, the escalating burden of chronic diseases is fueling the expansion of the preclinical imaging market.

How Is The Preclinical Imaging Market Organized Into Various Segments?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

How Are Emerging Trends Affecting The Progression Of The Preclinical Imaging Market?

Major companies in the preclinical imaging market are increasingly focusing on introducing next-generation imaging systems to secure a competitive edge. These next-generation systems embody advanced and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, unveiled next-generation imaging systems engineered to propel innovation across various applications in preclinical research. The recently launched products feature the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These advanced imaging systems are characterized by improved image-based capabilities and are designed to streamline the imaging workflow.

Who Are The Core Companies Influencing Trends In The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Regions Are Projected To Dominate The Preclinical Imaging Market In The Coming Years?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Preclinical Imaging Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Clinical Trial Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report

Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-imaging-global-market-report

Pediatric Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795